Full Text
Vitamin D is a fat-soluble hormone-like vitamin that plays a fundamental role in numerous physiological processes throughout the human body. Traditionally, its biological significance has been linked to calcium absorption, bone metabolism, and maintenance of skeletal integrity. However, growing scientific evidence indicates that vitamin D exerts widespread effects on various organ systems, including the reproductive, endocrine, immune, and cardiovascular systems. As a result, vitamin D deficiency has become an important focus of contemporary medical research.
Globally, vitamin D insufficiency affects a substantial proportion of women of reproductive age. Modern lifestyle changes, reduced sunlight exposure, dietary inadequacies, increased indoor activities, and certain cultural practices contribute significantly to the development of vitamin D deficiency. The prevalence of inadequate vitamin D levels remains particularly high among pregnant women, creating potential risks for both maternal and fetal health.
Recent advances in reproductive endocrinology have revealed the presence of vitamin D receptors in numerous reproductive tissues, including the ovaries, endometrium, placenta, and pituitary gland. These findings suggest that vitamin D participates directly in the regulation of reproductive processes. Through its interaction with specific cellular receptors, vitamin D influences follicular development, ovarian steroidogenesis, implantation, placental function, and immune tolerance during pregnancy.
Deficiency of vitamin D may negatively affect female fertility through multiple mechanisms. Hormonal imbalance, impaired follicular maturation, disrupted ovulation, and altered endometrial receptivity have all been associated with insufficient vitamin D status. Furthermore, low vitamin D concentrations are frequently observed in women diagnosed with polycystic ovary syndrome, one of the leading causes of infertility worldwide. Several studies suggest that correction of vitamin D deficiency may improve ovulatory function and reproductive outcomes in affected individuals.
Pregnancy represents a period of increased physiological demand for vitamin D. Adequate maternal vitamin D levels are essential for fetal skeletal development, immune regulation, placental growth, and maintenance of healthy pregnancy progression. Deficiency during gestation has been linked to a variety of maternal complications, including gestational diabetes mellitus, hypertensive disorders of pregnancy, preeclampsia, increased susceptibility to infections, and higher rates of cesarean delivery.
In addition to maternal consequences, vitamin D deficiency may adversely affect fetal and neonatal health. Insufficient prenatal vitamin D exposure has been associated with impaired fetal growth, low birth weight, premature birth, neonatal hypocalcemia, and altered immune development. Emerging evidence also suggests potential long-term effects on childhood health, including increased susceptibility to respiratory disorders, allergic diseases, and metabolic abnormalities.
The relationship between vitamin D status and reproductive health is further complicated by interactions with metabolic and inflammatory pathways. Vitamin D possesses immunomodulatory properties that help regulate inflammatory responses and support immune tolerance during pregnancy. Disturbances in these mechanisms may contribute to implantation failure, recurrent pregnancy loss, and adverse obstetric outcomes.
Despite increasing awareness of the importance of vitamin D, deficiency often remains undiagnosed due to the nonspecific nature of its clinical manifestations. Many women may present with subtle symptoms or remain asymptomatic until reproductive or pregnancy-related complications develop. Consequently, early detection through laboratory screening has gained considerable attention in reproductive medicine and prenatal care.
The growing burden of infertility and pregnancy complications worldwide underscores the need for improved understanding of modifiable risk factors affecting reproductive outcomes. Vitamin D deficiency represents one such factor that may be amenable to prevention and treatment through appropriate public health interventions and clinical management strategies.
The aim of this study was to investigate the influence of vitamin D deficiency on reproductive health and pregnancy outcomes in women, evaluate its association with fertility-related disorders and gestational complications, and assess the potential benefits of early identification and correction of inadequate vitamin D status.
2. Materials and Methods
This study was conducted between 2024 and 2025 at specialized obstetrics, gynecology, and reproductive health centers. A total of 180 women aged 20–40 years participated in the investigation. Participants were divided into three groups according to their serum vitamin D concentrations. Group I consisted of women with sufficient vitamin D levels, Group II included women with vitamin D insufficiency, and Group III comprised participants diagnosed with vitamin D deficiency.
All participants underwent comprehensive clinical evaluation, including detailed medical and reproductive history, physical examination, and laboratory investigations. Information regarding menstrual regularity, infertility duration, previous pregnancies, pregnancy complications, lifestyle factors, dietary habits, and sun exposure was collected using standardized questionnaires.
Laboratory assessment included measurement of serum 25-hydroxyvitamin D concentrations, calcium levels, phosphorus levels, parathyroid hormone concentrations, fasting glucose, insulin levels, and reproductive hormones such as follicle-stimulating hormone, luteinizing hormone, estradiol, progesterone, and anti-Müllerian hormone. Pregnant participants additionally underwent routine prenatal laboratory monitoring throughout gestation.
Ultrasonographic examination was performed to evaluate ovarian morphology, follicular development, endometrial thickness, and fetal growth parameters. Women diagnosed with infertility underwent further reproductive assessment according to standard clinical protocols.
Pregnancy outcomes were evaluated through monitoring of gestational age at delivery, birth weight, occurrence of gestational diabetes mellitus, hypertensive disorders, preeclampsia, preterm birth, fetal growth restriction, and neonatal health indicators. Statistical analysis was conducted using standard biomedical methods.
The findings demonstrated a significant association between vitamin D status and reproductive health indicators. Women with vitamin D deficiency exhibited a higher frequency of menstrual irregularities, ovulatory dysfunction, and fertility-related complications compared with participants maintaining adequate vitamin D concentrations.
Clinical assessment revealed that irregular menstrual cycles occurred more frequently among women with deficient vitamin D levels. Delayed ovulation, prolonged menstrual intervals, and hormonal imbalance were observed with increased prevalence in the deficiency group. These abnormalities were accompanied by alterations in reproductive hormone profiles, suggesting impaired endocrine regulation of ovarian function.
Infertility was identified more commonly among participants with low serum vitamin D concentrations. Women experiencing difficulty conceiving frequently demonstrated reduced ovarian reserve markers and less favorable follicular development during ultrasonographic evaluation. The probability of successful conception appeared significantly lower among individuals with persistent vitamin D deficiency.
A substantial proportion of women diagnosed with polycystic ovary syndrome exhibited inadequate vitamin D status. These participants demonstrated more pronounced metabolic disturbances, including insulin resistance and elevated body mass index. Lower vitamin D concentrations were associated with increased severity of endocrine dysfunction and reproductive impairment.
Among pregnant participants, vitamin D deficiency was associated with a higher incidence of gestational complications. Gestational diabetes mellitus occurred more frequently in women with insufficient vitamin D concentrations compared with those maintaining adequate levels. Similarly, hypertensive disorders of pregnancy and preeclampsia were observed with greater prevalence among vitamin D-deficient individuals.
Assessment of fetal outcomes revealed significant differences between study groups. Infants born to mothers with inadequate vitamin D status demonstrated lower average birth weights and increased frequency of preterm delivery. Cases of fetal growth restriction were also more common among pregnancies complicated by maternal vitamin D deficiency.
Neonatal evaluation showed that offspring of vitamin D-deficient mothers had a greater likelihood of requiring specialized postnatal observation. Although severe neonatal complications remained relatively uncommon, indicators of suboptimal intrauterine development were more frequently identified in this population.
Correlation analysis demonstrated a positive relationship between maternal vitamin D concentrations and favorable reproductive outcomes. Higher serum vitamin D levels were associated with improved ovulatory function, increased pregnancy success rates, lower incidence of obstetric complications, and healthier neonatal parameters.
The results of the present study confirm the growing body of evidence supporting the importance of vitamin D in female reproductive physiology and pregnancy maintenance. Beyond its classical role in mineral metabolism, vitamin D appears to function as a significant regulator of reproductive and endocrine processes.
One of the most notable findings was the association between vitamin D deficiency and impaired ovarian function. The presence of vitamin D receptors within ovarian tissue suggests a direct biological influence on follicular maturation and hormone production. Insufficient vitamin D availability may disrupt these physiological processes, contributing to menstrual irregularities and reduced fertility potential.
The observed relationship between vitamin D deficiency and infertility supports current theories regarding endometrial receptivity and embryo implantation. Adequate vitamin D concentrations may facilitate successful implantation through modulation of immune tolerance, cellular differentiation, and local hormonal signaling within reproductive tissues.
The high prevalence of vitamin D deficiency among women with polycystic ovary syndrome further highlights the interaction between vitamin D metabolism and endocrine disorders. Vitamin D may influence insulin sensitivity, inflammatory pathways, and androgen regulation, all of which are important factors in the pathophysiology of polycystic ovary syndrome.
Pregnancy outcomes observed in this investigation emphasize the significance of maintaining adequate vitamin D status throughout gestation. Maternal vitamin D deficiency was associated with increased susceptibility to gestational diabetes and hypertensive complications. These findings may be explained by the role of vitamin D in glucose metabolism, vascular function, immune regulation, and placental development.
The adverse fetal outcomes identified among vitamin D-deficient pregnancies suggest that maternal nutritional status directly affects intrauterine growth and fetal development. Adequate vitamin D availability appears essential for optimal placental function and fetal skeletal formation, while deficiency may contribute to restricted growth and premature birth.
The immunomodulatory properties of vitamin D may represent another important mechanism underlying reproductive success. Controlled immune responses are necessary for successful implantation and maintenance of pregnancy. Disturbances in these processes may increase the risk of pregnancy complications and adverse obstetric outcomes.
From a public health perspective, the widespread prevalence of vitamin D deficiency among women of reproductive age represents a potentially modifiable risk factor. Routine screening and early intervention may improve reproductive health outcomes and reduce the burden of pregnancy-related complications.
Although the study demonstrated significant associations, certain limitations should be acknowledged. Environmental factors, genetic variability, nutritional habits, and socioeconomic conditions may also influence reproductive outcomes. Further multicenter investigations involving larger populations are warranted to clarify the long-term benefits of vitamin D optimization in reproductive medicine.
The present study demonstrated that vitamin D deficiency exerts a significant negative influence on female reproductive health and pregnancy outcomes. Inadequate vitamin D status was associated with menstrual disturbances, ovulatory dysfunction, infertility, polycystic ovary syndrome severity, and unfavorable hormonal profiles.
Pregnant women with vitamin D deficiency exhibited increased risk of gestational diabetes mellitus, hypertensive disorders, preeclampsia, preterm birth, and fetal growth restriction. Furthermore, maternal vitamin D status was closely associated with neonatal health indicators and overall pregnancy success.
The findings emphasize the importance of routine assessment of vitamin D concentrations among women of reproductive age and during pregnancy. Early identification and correction of vitamin D deficiency may contribute to improved fertility, healthier pregnancy progression, and enhanced maternal and neonatal outcomes.
Integration of vitamin D screening into reproductive healthcare programs represents a practical and potentially effective strategy for reducing preventable complications and promoting optimal reproductive health. Continued research is required to establish evidence-based recommendations regarding vitamin D supplementation and long-term reproductive outcomes.
[1] Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281.
[2] Pilz S, Zittermann A, Obeid R, et al. The role of vitamin D in fertility and reproductive health. Nutrients. 2018;10(2):224.
[3] Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012;166(5):765–778.
[4] Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O’Beirne M, Rabi DM. Association between maternal vitamin D status and pregnancy outcomes: a systematic review and meta-analysis. BMJ. 2013;346:f1169.
[5] Wei SQ, Qi HP, Luo ZC, Fraser WD. Maternal vitamin D status and adverse pregnancy outcomes. CMAJ. 2013;185(9):E463–E470.
[6] Palacios C, De-Regil LM, Lombardo LK, Peña-Rosas JP. Vitamin D supplementation during pregnancy. Cochrane Database Syst Rev. 2016;(1):CD008873.
[7] Perez-Lopez FR, Pasupuleti V, Mezones-Holguin E, et al. Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes. Fertil Steril. 2015;103(5):1278–1288.
[8] Harvey NC, Holroyd C, Ntani G, et al. Vitamin D supplementation in pregnancy and offspring bone health. Lancet Diabetes Endocrinol. 2014;2(2):106–113.
[9] Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin D. Endocr Rev. 2019;40(4):1109–1151.
[10] Mousa A, Naqash A, Lim S. Macronutrient and micronutrient intake during pregnancy and fertility. Nutrients. 2019;11(2):443.
[11] Irani M, Merhi Z. Role of vitamin D in ovarian physiology and fertility. Reprod Biol Endocrinol. 2014;12:142.
[12] Franasiak JM, Molinaro TA, Dubell EK, et al. Vitamin D levels and reproductive outcomes in women undergoing fertility treatment. Fertil Steril. 2015;104(3):659–664.
[13] Chu J, Gallos I, Tobias A, et al. Vitamin D and assisted reproductive treatment outcomes: a systematic review and meta-analysis. Hum Reprod. 2018;33(1):65–80.
[14] Roth DE, Leung M, Mesfin E, Qamar H, Watterworth J, Papp E. Vitamin D supplementation during pregnancy: state of the evidence. BMJ. 2017;359:j5237.
[15] American College of Obstetricians and Gynecologists. Vitamin D screening and supplementation during pregnancy. Committee Opinion No. 495. Obstet Gynecol. 2021;137(6):e177–e182.
[16] World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: WHO; 2024.
[17] World Health Organization. Micronutrient deficiencies: Vitamin D deficiency. Geneva: WHO; 2025.
[18] European Society of Human Reproduction and Embryology (ESHRE). Guideline on nutrition, fertility and reproductive health. ESHRE; 2024.
[19] Med1.uz. D vitamini yetishmovchiligi va ayollar salomatligi. Available from: https://med1.uz/articles/ginekologiya/d-vitamini
[20] Med1.uz. Homiladorlik davrida vitamin D ning ahamiyati. Available from: https://med1.uz/articles/akusherlik/homiladorlik-d-vitamini
[21] Med1.uz. Reproduktiv salomatlik va mikronutrientlar. Available from: https://med1.uz/articles/ginekologiya/reproduktiv-salomatlik
[22] Med1.uz. Ayollarda endokrin buzilishlar va vitamin D. Available from: https://med1.uz/articles/endokrinologiya/vitamin-d
[23] Med1.uz. Bepushtlikning metabolik va gormonal omillari. Available from: https://med1.uz/articles/ginekologiya/bepushtlik
[24] Med1.uz. Homiladorlik asoratlarining profilaktikasi. Available from: https://med1.uz/articles/akusherlik/profilaktika
[25] Med1.uz. Vitaminlar va mineral moddalar yetishmovchiligi diagnostikasi. Available from: https://med1.uz/articles/laboratoriya/vitamin-diagnostika
[26] Med1.uz. Zamonaviy akusherlikda prenatal parvarish tamoyillari. Available from: https://med1.uz/articles/akusherlik/prenatal-parvarish